Table 1.
Clinical and Demographic characteristics of subjects involved in the study with respect to number of individuals, age of diagnosis, duration of disease, genotype and antibody number.
| Variable | AbN | AbP | T1D |
| Total number | 117 | 19 | 82 |
| Age (years) | 15.1 | 14.5 | 15.8 |
| 75%ile | 22.0 | 28.5 | 20.1 |
| 90%ile | 37.0 | 37.0 | 36.0 |
| Age range | (0.8–48.6) | (0.6–44.0) | (0.9–43.7) |
| Age of Diagnosis (years) | 8.8 (0.8–41.2) | ||
| Duration of T1D (years) | 6.2 (0–41.0) | ||
| Age: n (percent) | |||
| <20 years | 86 (73.51) | 14 (73.68) | 60 (73.17) |
| >20 years | 31 (26.49) | 5 (26.32) | 22 (26.83) |
| Sex: n (percent) | |||
| Male | 53 (45.30) | 9 (47.37) | 50 (60.97) |
| Female | 64 (54.70) | 10 (52.63) | 32 (39.03) |
| Genotype: n (percent)* | |||
| 0201/0201 | 8 (6.84) | 0 (0.00) | 13 (15.85) |
| 0302/0302 | 12 (10.26) | 4 (21.05) | 6 (7.32) |
| 0201/0302 | 31 (26.50) | 5 (26.32) | 38 (46.34) |
| 0201/x | 21 (17.95) | 3 (15.79) | 10 (12.20) |
| 0302/x | 23 (19.66) | 4 (21.05) | 11 (13.41) |
| x/x | 18 (15.38) | 2 (10.53) | 3 (3.66) |
Age, age of diagnosis and duration of disease is presented as means (range).
*Genotyping information was not available on one AbP, one T1D and 4 AbN individual(s).
Sex and genotype are presented as number of individuals of individuals (n). Values presented in parenthesis are percentage of total.